Entero Healthcare Solutions (ENTERO) Fundamentals 2026 — P/E 46.9x, Revenue Analysis | SniperIQ
Entero Healthcare Solutions (ENTERO) is a India-listed Healthcare company in Medical - Distribution with a market capitalization of ₹5,394 Crore, trading at ₹1239.30 on the NSE. This SniperIQ fundamentals page covers Entero Healthcare Solutions's valuation (P/E 46.9x, P/B 3.2x), profitability (net margin 1.7%), revenue (₹6,591 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Entero Healthcare Solutions's market cap?
Entero Healthcare Solutions (ENTERO) has a market capitalization of approximately ₹5,394 Crore, trading at ₹1239.30 on the NSE. Market cap moves with the live share price.
What is Entero Healthcare Solutions's P/E ratio?
Entero Healthcare Solutions's trailing twelve-month P/E ratio is 46.9x, with a price-to-book (P/B) of 3.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Entero Healthcare Solutions?
Entero Healthcare Solutions runs a net profit margin of 1.7%, a gross margin of 9.1%, and an operating margin of 3.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Entero Healthcare Solutions generate?
Entero Healthcare Solutions reported revenue of ₹6,591 Crore for fiscal year 2026, with net income of ₹115 Crore and earnings per share (EPS) of 26.44. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Entero Healthcare Solutions pay a dividend?
Entero Healthcare Solutions does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Entero Healthcare Solutions financially healthy?
Entero Healthcare Solutions carries a debt-to-equity ratio of 0.40x and a current ratio of 1.58x, with a market beta of -0.61. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Entero Healthcare Solutions a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Entero Healthcare Solutions (ENTERO) the key facts are: market cap ₹5,394 Crore, P/E 46.9x, revenue ₹6,591 Crore, 52-week range 944-1390. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Entero Healthcare Solutions's full fundamentals live
Get Entero Healthcare Solutions's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.